tel: 800.260.6780 (toll free) • 330.670.0101 (phone) • fax: 330.670.0109 • email: email@example.com
© 2022 Association of Nurses in AIDS Care. All rights reserved.
PrEP (pre-exposure prophylaxis), is an FDA-approved daily regimen of anti-HIV medications that greatly reduces risk of infection for HIV-negative people. Daily PrEP (Truvada) has proven to be safe and highly effective, reducing the risk of getting HIV from sex by more than 90 percent. Among people who inject drugs, it reduces the risk by more than 70 percent. It is FDA approved and the CDC has issued guidelines for use in individuals at high risk.
The risk of getting HIV from sex can be even lower when PrEP is combined with condoms and other prevention methods. Inconsistent use of PrEP results in much lower levels of protection.
Nurses are critical to getting the word out about PrEP and how it can further HIV prevention. Education, initial screenings and continued follow-up are essential to its success. Talking to patients about their sexual health and routinely taking a sexual history is an important process for identifying patients at risk of acquiring HIV and other STIs. Approximately 40,000 people in the United States become infected with HIV each year according to the CDC. Gay and bisexual men, particularly young African American gay and bisexual men, are most affected.
Clinician PrEP Consultation Center
Provides clinically supported advice on PrEP for healthcare providers and up-to-date clinical consultation for PrEP decision-making.
Call for a phone consultation:
(855) 448-7737 or (855) HIV-PrEP
Monday – Friday, 11 a.m. – 6 p.m. EST
Connect to a national PrEP provider directory to find a local PrEP provider or register as a PrEP provider.